Glucoamylase variants and polynucleotides encoding same

US9534239B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9534239-B2
Application numberUS-201214343278-A
CountryUS
Kind codeB2
Filing dateSep 5, 2012
Priority dateSep 6, 2011
Publication dateJan 3, 2017
Grant dateJan 3, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to glucoamylase variants having reduced sensitivity to protease nicking. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

First claim

Opening claim text (preview).

The invention claimed is: 1. A glucoamylase variant, comprising a substitution at least at a position corresponding to position 79 of the mature polypeptide of SEQ ID NO: 2, wherein the variant has glucoamylase activity. 2. The glucoamylase variant of claim 1 , selected from the group consisting of: a) a polypeptide having at least 90% sequence identity to the mature polypeptide of SEQ ID NO: 2; and b) a polypeptide encoded by a polynucleotide that hybridizes under high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 1, or (ii) the full-length complement of (i), wherein the high stringency conditions include hybridization in 50% formamide, 1 M NaCl, 1% SDS at 37° C. 3. The glucoamylase variant of claim 1 , wherein the variant is a polypeptide having at least 95% sequence identity to the polypeptide of SEQ ID NO: 2. 4. The glucoamylase variant of claim 1 , wherein the number of substitutions is 1-20, 1-10 or 1-5. 5. The glucoamylase variant of claim 1 , wherein the variant comprises a substitution selected from K79V, K79A, K79G, K79I, K79L, K79S, K79T. 6. The glucoamylase variant of claim 1 , wherein the variant comprises substitution K79V. 7. A variant glucoamylase catalytic domain comprising a substitution at least at a position corresponding to position 79 of the mature polypeptide of SEQ ID NO: 2, wherein the variant has glucoamylase activity. 8. The variant glucoamylase catalytic domain of claim 7 selected from the group consisting of: (a) a catalytic domain having at least 95% sequence identity to amino acids 30 to 494 of SEQ ID NO: 2; and wherein the catalytic domain has glucoamylase activity. 9. A composition comprising the glucoamylase variant of claim 1 .

Assignees

Inventors

Classifications

  • C12C5/004Primary

    Enzymes · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

  • obtained by saccharification of starch or raw materials containing starch · CPC title

  • C12P7/14Primary

    Multiple stages of fermentation; Multiple types of microorganisms or re-use of microorganisms · CPC title

  • Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9534239B2 cover?
The present invention relates to glucoamylase variants having reduced sensitivity to protease nicking. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Who is the assignee on this patent?
Matsui Tomoko, Clark Suzanne, Novozymes As
What technology area does this patent fall under?
Primary CPC classification C12C5/004. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).